Perspectives of solution to the problem of persistent intra-abdominal hemorrhage at the prehospital stage

封面

如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

A post-hoc analysis of 338 casualties demonstrating persistent intra-abdominal hemorrhage has been carried out, the proportion of this group being 16.5% in overall casualty structure or 64% in the group of casualties with abdominal injuries. Lethal outcome rate in the studied group was 13%, the complication rate was 53.2%. Traumatic shock was found in 86% of casualties, the greatest proportion was accounted for by the first and second degree (59.1%). Lethality rate in the case of the third degree traumatic shock and terminal state was 34.4%. Injured parenchymal organs and abdominal major vessels showed the greatest blood loss — 2348 ± 250 ml. The time of arrival of casualties with persistent intra-abdominal hemorrhage to the advanced trauma management stage or definitive surgical care stage was virtually similar amounting to 2.6 ± 0.4 hr. Injuries to hollow organs (34.1%) were most commonly found, injuries to parenchymal organs (24.9%) occurred less frequently, the rate of combination of injuries to abdominal internal organs was approximately the same (24.9%). Major vessels injuries were diagnosed only in one casualty (0.3%), while those combined with internal organs injuries — in 37(11%)of casualties. As regards favorable prognosis this group was considered to be the least perspective owing to high rate of hemorrhage and inability to achieve effective hemostasis at the prehospital stage. Thus, persistent hemorrhage was not profuse, and the majority of casualties (88.7%) should be considered as perspective “recipients” to achieve temporary hemostasis at the prehospital stage. It is this approach based on the principles of early pathogenetic management that could reduce the rate of complications and lethality in casualties with persistent intra-abdominal hemorrhage.

作者简介

Konstantin Golovko

Military Medical Academy named after S.M. Kirov; Saint Petersburg State University

编辑信件的主要联系方式.
Email: vmeda-nio@mail.ru

Доктор медицинских наук, доцент

俄罗斯联邦, Saint Petersburg; Saint Petersburg

Igor Samokhvalov

Military Medical Academy named after S.M. Kirov

Email: igor-samokhvalov@mail.ru

Doctor of medical sciences, professor

俄罗斯联邦, Saint Petersburg

Maxim Grishin

Military Medical Academy named after S.M. Kirov

Email: al13max@mail.ru

Adjunct

俄罗斯联邦, Saint Petersburg

Tatyana Suprun

Military Medical Academy named after S.M. Kirov

Email: tat-suprun@yandex.ru

Сandidate of biological sciences

俄罗斯联邦, Saint Petersburg

Artem Nosov

Military Medical Academy named after S.M. Kirov

Email: artem_svu06@mail.ru

Сandidate of medical sciences

俄罗斯联邦, Saint Petersburg

Elena Dmitrieva

Military Medical Academy named after S.M. Kirov

Email: artem_svu06@mail.ru

Junior researcher

俄罗斯联邦, Saint Petersburg

Arkady Kovalevsky

Military Medical Academy named after S.M. Kirov

Email: kovalevskiy.arkadiy@mail.ru

Student of the faculty of training

俄罗斯联邦, Saint Petersburg

参考

  1. Samokhvalov IM, Goncharov AV, Chirskij VS, et al. «Potencial'no spasaemye» ranenye – rezerv snizheniya dogospital'noj letal'nosti pri raneniyah i travmah perspektivy. Skoraja medicinskaja pomosh. 2019;(3):10–16. (In Russ.)
  2. Samokhvalov IM, Golovko KP, Bojarincev VV, et al. Obosnovanie koncepcii rannego patogeneticheskogo lecheniya tyazhelyh ranenij i travm. Vestnik Rossijskoj Voenno-medicinskoj akademii. 2020;71(3):23–28. (In Russ.)
  3. Kotwal RS, Montgomery HR, Kotwal BM, et al. Eliminating preventable death on the battlefield. Arch Surg. 2011;146(12):1350–1358. doi: 10.1001/archsurg.2011.213
  4. Eastridge BJ, Stansbury LG, Stinger H, et al. Forward Surgical Teams provide comparable outcomes to combat support hospitals during support and stabilization operations on the battlefield. J Trauma. 2009;66(4 Suppl):S48–S50. doi: 10.1097/TA.0b013e31819ce315
  5. Holcomb JB, McMullin NR, Pearse L, et al. Causes of death in U.S. Special Operations Forces in the global war on terrorism: 2001–2004. Ann Surg. 2007;245(6):986–991. doi: 10.1097/01.sla.0000259433.03754.98
  6. Krjukov EV, editor. Primenenie sredstv immobilizacii, ostanovki krovotechenija i jevakuacii pri okazanii pervoj i dovrachebnoj pomoshhi ranenym i postradavshim s povrezhdenijami oporno-dvigatel'noj sistemy Moscow; 2019. (In Russ).
  7. Smith S, White J, Nashat Wanis K, et al. The effectiveness of junctional tourniquets: A systematic review and meta-analysis. Meta-Analysis. J Trauma Acute Care Surg. 2019;86(3):532–539. doi: 10.1097/TA.0000000000002159
  8. Rago AP, Duggan MJ, Hannett P, et al. Chronic safety assessment of hemostatic self-expanding foam: 90-day survival study and intramuscular biocompatibility. J Trauma Acute Care Surg. 2015;79(4 Suppl 2):S78–S84. doi: 10.1097/TA.0000000000000571
  9. Rappold JF, Bochicchio GV. Surgical adjuncts to noncompressible torso hemorrhage as tools for patient blood management. Transfusion. 2016;56 Suppl 2:S203–S207. doi: 10.1111/trf.13585
  10. Benov A, Shkolnik I, Glassberg E, et al. Prehospital trauma experience of the Israel defense forces on the Syrian border 2013–2017. J Trauma Acute Care Surg. 2019;87(1S Suppl 1):S165–S171. doi: 10.1097/TA.0000000000002217
  11. CRASH-2 trial collaborators, Shakur H, Roberts I, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376(9734):23–32. doi: 10.1016/S0140-6736(10)60835-5
  12. Morrison JJ, Dubose JJ, Rasmussen TE, et al. Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study. Arch Surg. 2012;147(2):113–119. doi: 10.1001/archsurg.2011.287
  13. Kotwal RS, Butler FK Jr. Junctional Hemorrhage Control for Tactical Combat Casualty Care. Wilderness Environ Med. 2017;28(2S):S33–S38. doi: 10.1016/j.wem.2016.11.007
  14. Brännström A, Rocksén D, Hartman J, et al. Abdominal Aortic and Junctional Tourniquet release after 240 minutes is survivable and associated with small intestine and liver ischemia after porcine class II hemorrhage. J Trauma Acute Care Surg. 2018;85(4):717–724. doi: 10.1097/TA.0000000000002013
  15. Rall JM, Ross JD, Clemens MS, et al. Hemodynamic effects of the Abdominal Aortic and Junctional Tourniquet in a hemorrhagic swine model. J Surg Res. 2017;212:159–166. doi: 10.1016/j.jss.2017.01.020
  16. Anonymous. Abdominal aortic tourniquet? Use in Аfghanistan. J Spec Oper Med. 2013;13(2):1–2.
  17. Tovmassian RV, Kragh JF Jr, Dubick MA, et al. Combat ready clamp medic technique. J Spec Oper Med. 2012;12(4):72–78.
  18. Brown SR, Reed DH, Thomas P, et al. Successful Placement of REBOA in a Rotary Wing Platform Within a Combat Theater: Novel Indication for Partial Aortic Occlusion. J Spec Oper Med. 2020;20(1):34–36.
  19. Manley JD, Mitchell BJ, DuBose JJ, et al. A Modern Case Series of Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) in an Out-of-Hospital, Combat Casualty Care Setting. J Spec Oper Med. 2017;17(1):1–8.
  20. Reva VA, Petrov AN, Samokhvalov IM. Pervyj otechestvennyj opyt primeneniya endovaskulyarnoj ballonnoj okklyuzii aorty v zone boevyh dejstvij. Angiologija i sosudistaja hirurgija. 2020;26(2):61–75. (In Russ.)
  21. Fisher AD, Teeter WA, Cordova CB, et al. The Role I Resuscitation Team and Resuscitative Endovascular Balloon Occlusion of the Aorta. J Spec Oper Med. 2017;17(2):65–73.
  22. Cantle PM, Hurley MJ, Swartz MD, et al. Methods for Early Control of Abdominal Hemorrhage: An Assessment of Potential Benefit. J Spec Oper Med. 2018;18(2):98–104.
  23. Gumanenko E.K. Voenno-polevaja hirurgija: uchebnik. Moscow: GEOTAR-Media, 2008. Prilozhenie 1. (In Russ.)
  24. Lewis KM, Li Q, Jones DS, et al. Development and validation of an intraoperative bleeding severity scale for use in clinical studies of hemostatic agents. Surgery. 2017;161(3):771–781. doi: 10.1016/j.surg.2016.09.022

补充文件

附件文件
动作
1. JATS XML

版权所有 © Golovko K.P., Samokhvalov I.M., Grishin M.S., Suprun T.Y., Nosov A.M., Dmitrieva E.V., Kovalevsky A.Y., 2021

Creative Commons License
此作品已接受知识共享署名-非商业性使用-禁止演绎 4.0国际许可协议的许可。

##common.cookie##